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ABSTRACT
Dermatomyositis (DM) and sarcoidosis are two idiopathic systemic disorders. Reports of patients with both conditions are extremely rare. 
Here we describe two patients who presented with DM and DM-associated antibodies, and later developed biopsy-proven sarcoidosis. 
There are increasing reports of the occurrence of sarcoidosis in the context of autoimmune diseases. These observations might imply 
similarities in the pathogenetic mechanisms. 
LEARNING POINTS
• Sarcoidosis should be considered in patients with dermatomyositis (DM) presenting with enlarged lymph nodes. Contrary to the principle 
of Occam’s razor, in this case one diagnosis does not rule out the other.
•	 The	pathophysiology	of	sarcoidosis	and	DM	involves	both	Th1	and	Th17	 inflammatory	responses,	which	may	explain	the	overlap	of	
these two diseases
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INTRODUCTION
Dermatomyositis (DM) and sarcoidosis are two idiopathic systemic disorders. Reports of patients with both conditions are very rare, and 
mostly concern patients of Asian origin. Here we describe two patients presenting with DM relapsing as sarcoidosis.
CASE REPORT
Patient 1 was a 53-year-old North African woman with a history of in situ ductal breast carcinoma that was treated surgically 10 years 
before she presented with a violaceous rash on the dorsal aspects of her hands. She had no complaints of muscle weakness or exertional 
dyspnoea. Cardiopulmonary auscultation and evaluation of muscle force were normal. She had a painful periungual erythema on the 
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dorsal surfaces of her distal interphalangeal (DIP), proximal interphalangeal (PIP) and metacarpophalangeal (MCP) joints, consistent with 
Gottron’s	 papules,	 and	 splinter	 haemorrhages	 under	 her	 fingernails.	 There	 was	 no	 eyelid	 erythema.	 Laboratory	 examinations	 showed	
normal erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels, normal renal function, and normal electrolyte and muscle 
enzyme	levels.	A	positive	anti-nuclear	factor	was	detected	at	a	1:5,000	titre,	with	identification	of	anti-Mi2	antibodies.	The	diagnosis	of	
amyopathic	DM	was	established,	and	first-line	treatment	with	hydroxychloroquine	400	mg	daily	was	 initiated.	A	computed	tomography	
scan of the chest for cancer screening revealed nodular pulmonary lesions and bilaterally enlarged hilar mediastinal lymph nodes. Lymph 
node biopsy by mediastinoscopy demonstrated non-caseating granulomas (Fig. 1), without evidence of neoplasia or mycobacterial infection. 
Other	laboratory	findings	were	elevated	angiotensin	converting	enzyme	(ACE)	(59	IU/l;	normal	(N)<55	IU/l)	and	CRP	(81	mg/l;	N<10	mg/l)	
levels. A diagnosis of sarcoidosis complicating DM was made. Follow-up 3 years later showed muscular weakness and mildly elevated 
creatinine phosphokinase (CK) titres, along with elevated ACE. Electromyography showed a myopathic pattern compatible with myositis, 
and	a	muscle	biopsy	showed	necrotic	muscle	fibres,	mostly	invaded	by	macrophages	and	reactive	for	acid	phosphatase.	These	fibres	were	
mainly peripherally located and showed focal peri-fascicular atrophy (Fig. 2D). The overall picture suggested full-blown DM complicated by 
pulmonary	sarcoidosis.	Treatment	with	corticosteroids	resulted	in	total	remission	of	the	inflammatory	conditions.	
Figure 1.Lymph node biopsy findings in patient 1. Haematoxylin-eosin staining 
shows non-necrotizing granulomatosis of a right latero-tracheal lymph node. 
Figure 2. Muscle biopsy findings. (A) Haematoxylin-eosin (H&E) staining showing 
myositis characterized by necrotic fibres and particularly a marked interstitial 
(endomysial) inflammatory infiltrate composed mainly of mononuclear leucocytes. 
(B) Inflammatory cells were strongly labelled with immunohistochemical staining for 
CD3 (a lymphocytic marker; darkly labelled cells). (C) Horizontal sections showing 
perifascicular atrophy (small atrophic fibres at the periphery of fascicles; dark arrows). 
(D) Necrotic fibres (white arrows) invaded by macrophages and focal perifascicular 
atrophy (dark arrows). A,B,C: paraffin sections from patient 2; D: frozen section (H&E 
stain) from patient 1. Original magnification: ×160 (A,D), ×100 (B) and ×80 (C). the 
late phase of examination.
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Figure 3. Lymph node biopsy findings in patient 2. Haematoxylin-eosin staining 
shows diffuse histocytosis of a mediastinal lymph node. 
Patient 2 was a 19-year-old Caucasian woman who presented with a 2-year history of arthralgias and skin lesions that had been previously 
diagnosed as psoriasis. Physical examination showed Gottron’s papules on both hands, while muscle examination was normal. Laboratory 
explorations	 showed	 normal	 ESR	 and	 CRP	 levels,	 markedly	 elevated	 CK	 levels	 (2800	 IU/l,	 N<308),	 normal	 ACE	 levels	 and	 positive	
antinuclear	 factor	 at	 a	1:80	 titre	with	 anti-Jo1	 identification.	Radiographic	 evaluation	of	 the	 lungs	 showed	 infiltrates	 corresponding	 to	
interstitial pneumonia. Respiratory function tests showed diminished diffusion capacity, at 68% of DLCO/VA. Electromyography (deltoid 
and	 rectus	 femoris)	 showed	 a	myopathic	 pattern	 suggestive	 of	myositis.	Muscle	 biopsy	 (quadriceps	 femoris)	 showed	 an	 inflammatory	
myositis	characterized	by	necrotic	fibres	and	mainly	an	interstitial/perivascular	inflammatory	mononuclear	leucocytic	infiltrate	that	was	
predominantly CD4-positive with immunohistological staining. There were also foci of perifascicular atrophy, and ‘atypical’ or ‘pseudo’ 
granulomas were sometimes suspected (Fig. 2A–C). This patient with DM in a context of anti-synthetase syndrome responded well to 
corticosteroids.	During	 a	myositis	flare	7	 years	 later,	 examination	 showed	enlarged	mediastinal	 lymph	nodes,	 along	with	 an	 interstitial	
pneumonia	 and	 abnormal	 fixation	 on	 PET	 scan.	 Broncho-alveolar	 lavage	 showed	 a	 CD4/CD8	 ratio	 of	 0.61	 (N>1.3)	 and	 elevated	 ACE	
serum levels were also observed. Lymph node biopsy revealed marked histiocytosis, compatible with the diagnosis of sarcoidosis. (Fig. 3) 
Immunosuppressive treatment with azathioprine and corticosteroids led to the resolution of both myositis and sarcoidosis. 
DISCUSSION
We report two cases of DM complicated by sarcoidosis. We found only nine cases in the literature (mainly Asian patients) who presented 
with DM complicated by sarcoidosis[1]. However, there are increasing reports of the occurrence of sarcoidosis in the context of other 
autoimmune diseases[1]. These observations might imply a common pathogenetic pathway. Facco et al.[2] demonstrated the role of Th1 and 
Th17 responses in the pathogenesis of sarcoidosis, while the marked IFN-γ signature in myositis and the elevated IL-17 levels underline 
the	participation	of	both	pathways	in	the	development	of	inflammatory	myopathies[3, 4]. While the precise aetiology of sarcoidosis remains 
elusive,	prolonged	inflammation	could	be	a	triggering	element	in	its	pathogenesis,	and	chronic	inflammation	(including	that	involved	in	DM)	
might trigger the formation of granulomas[5].
Our observations were made over a period of 7 years. As the clinical spectrum of sarcoidosis ranges from asymptomatic to life-threatening, 
it is possible that cases of sarcoidosis are missed in patients with other, more severe diseases. However, it remains a diagnosis that should 
be considered, especially since lymphadenopathy may suggest malignant disease in the setting of DM. The opposite is also valid; patients 
developing myositis in the context of biopsy-proven sarcoidosis could in fact be developing DM or another autoimmune disease. Myositis-
specific	and	myositis-associated	antibodies	help	in	the	diagnosis,	as	demonstrated	by	our	cases.
In conclusion, we report on two cases of DM complicated by sarcoidosis, an association which is extremely rare. A common aetiopathogenic 
mechanism	underlying	these	immune-inflammatory	conditions	is	discussed.
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